Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anti-platelet Therapy”

123 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 123 results

Not applicableStudy completedNCT01175200
What this trial is testing

Double the Dose of Clopidogrel or Switch to Prasugrel to Antagonize Proton Pump Inhibitor Interaction.

Who this might be right for
Anti Platelet Effects
Ascopharm Groupe Novasco 82
Testing effectiveness (Phase 2)Looking for participantsNCT06838962
What this trial is testing

Anti-CD38 Antibody Treating Children With Primary Immune Thrombocytopenia (ITP)

Who this might be right for
Immune ThrombocytopeniaTreatment
Institute of Hematology & Blood Diseases Hospital, China 30
Very early researchStudy completedNCT00727948
What this trial is testing

The Effect of Aspirin on Angiogenesis Proteins in Women on Tamoxifen Therapy

Who this might be right for
Breast CancerAngiogenesis
University of Vermont 11
Not applicableLooking for participantsNCT06973356
What this trial is testing

Anti CD19/BCMA CAR Gene Therapy for Relapsed/Refractory Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia (ITP)
Anhui Provincial Hospital 18
Testing effectiveness (Phase 2)Study completedNCT00656175
What this trial is testing

Raltegravir Therapy for Women With HIV and Fat Accumulation

Who this might be right for
HIV InfectionsLipodystrophy
University of California, Los Angeles 39
Not applicableStudy completedNCT01925794
What this trial is testing

COBRA PZF™ Coronary Stent for Early Healing, Thrombus Inhibition, Endothelialization and Avoiding Long-Term DAPT

Who this might be right for
Coronary Artery Disease
CeloNova BioSciences, Inc. 296
Not applicableLooking for participantsNCT05907629
What this trial is testing

Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis- Magnetic Resonance Imaging

Who this might be right for
StrokeIntracranial Atherosclerotic Stenosis (ICAS)
Yale University 300
Testing effectiveness (Phase 2)Looking for participantsNCT06094881
What this trial is testing

A Prospective, One-arm and Open Clinical Study of Obinutuzumab in the Treatment of Pediatric Primary Immune Thrombocytopenia (ITP)

Who this might be right for
Immune ThrombocytopeniaTreatment
Institute of Hematology & Blood Diseases Hospital, China 60
Post-approval studies (Phase 4)UnknownNCT00954707
What this trial is testing

CYPRESS - CYPHER for Evaluating Sustained Safety

Who this might be right for
Coronary Artery Disease
Cordis US Corp. 2,509
Large-scale testing (Phase 3)Looking for participantsNCT05935215
What this trial is testing

Efficacy and Safety of Switching From Anti-C5 Antibody Treatment to Iptacopan Treatment in Study Participants With Atypical Hemolytic Uremic Syndrome (aHUS)

Who this might be right for
Atypical Hemolytic Uremic Syndrome
Novartis Pharmaceuticals 50
Large-scale testing (Phase 3)Looking for participantsNCT04915482
What this trial is testing

TPO-RAs Combined With Anti-CD20 Antibody in the Treatment of Adult Immune Thrombocytopenia With Autoantibodies

Who this might be right for
Immune Thrombocytopenia (ITP)AutoantibodiesEvan Syndrome+1 more
Institute of Hematology & Blood Diseases Hospital, China 94
Testing effectiveness (Phase 2)Study completedNCT00061373
What this trial is testing

Combination Anti-Platelet and Anti-Coagulation Treatment After Lysis of Ischemic Stroke Trial (CATALIST)

Who this might be right for
Ischemic Stroke
National Institute of Neurological Disorders and Stroke (NINDS) 18
Post-approval studies (Phase 4)Study completedNCT04006288
What this trial is testing

Switching From DAPT to Dual Pathway Inhibition With Low-dose Rivaroxaban in Adjunct to Aspirin in Patients With Coronary Artery Disease

Who this might be right for
Coronary Artery Disease
University of Florida 90
Early research (Phase 1)Study completedNCT00768391
What this trial is testing

Study of IMC-3G3 in Patients With Tumors That Are Not Responding to Standard Therapies or No Therapy is Available

Who this might be right for
Solid Tumors
Eli Lilly and Company 20
Testing effectiveness (Phase 2)Study completedNCT03487406
What this trial is testing

Anti-platelet Therapy in the Prevention of Cardiovascular Disease in Patients With COPD (APPLE-COPD: ICON 2)

Who this might be right for
Chronic Obstructive Pulmonary Disease (COPD)
Newcastle-upon-Tyne Hospitals NHS Trust 120
Early research (Phase 1)Ended earlyNCT01561950
What this trial is testing

Efficacy of Activated Recombinant Human Factor VII in Healthy Volunteers Treated for Punch Biopsy Mediated Bleeding

Who this might be right for
HaemostasisHealthy
Novo Nordisk A/S 91
Post-approval studies (Phase 4)UnknownNCT04088513
What this trial is testing

Safety and Efficacy of Aspirin in Stroke Patients With Glucose-6-phosphate Dehydrogenase Deficiency (SAST)

Who this might be right for
G6PD DeficiencyStroke
First Affiliated Hospital, Sun Yat-Sen University 440
Testing effectiveness (Phase 2)Looking for participantsNCT06792643
What this trial is testing

Cangrelor on Top of anticoagUlation in Patients With myocaRdial Infarction-related Cardiogenic Shock/Cardiac Arrest receiVIng VA-ECMO

Who this might be right for
Cardiogenic ShockExtracorporeal Membrane Oxygenation ComplicationPlatelet Dysfunction
IRCCS San Raffaele 50
Large-scale testing (Phase 3)Study completedNCT01184300
What this trial is testing

ReAssessment of Anti-Platelet Therapy Using an InDividualized Strategy Based on GENetic Evaluation

Who this might be right for
Stable Coronary Artery DiseaseAcute Coronary SyndromePercutaneous Coronary Intervention
Ottawa Heart Institute Research Corporation 200
Testing effectiveness (Phase 2)Ended earlyNCT00547066
What this trial is testing

Study of Veltuzumab (hA20) at Different Doses in Patients With ITP

Who this might be right for
Purpura, Thrombocytopenic, IdiopathicAutoimmune Thrombocytopenic PurpuraPurpura, Thrombocytopenic, Autoimmune
Gilead Sciences 48
Load More Results